Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
STAA Staar Surgical Co
- Stocks
- Healthcare
- NASDAQ: STAA
Price (delayed)
$19.22
Market cap
$951.89M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.45
Enterprise value
$815.46M
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are
Highlights
Staar Surgical's debt has decreased by 5% from the previous quarter but it has increased by 2.8% YoY
STAA's quick ratio is down by 22% YoY and by 13% QoQ
The gross profit has declined by 19% year-on-year and by 14% since the previous quarter
Key stats
What are the main financial stats of STAA
Market
Valuations
Earnings
Shares outstanding
49.53M
Market cap
$951.89M
Enterprise value
$815.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.71
Price to sales (P/S)
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.92
Revenue
$279.13M
Gross profit
$206.55M
Operating income
-$67.73M
Net income
-$71.08M
EBIT
-$61.33M
EBITDA
-$53.34M
Free cash flow
-$31.35M
Per share
Balance sheet
Liquidity
EPS
-$1.45
EPS diluted
-$1.44
Free cash flow per share
-$0.64
Book value per share
$7.1
Revenue per share
$5.66
TBVPS
$9.23
Total assets
$457.36M
Total liabilities
$107.39M
Debt
$36.68M
Equity
$349.97M
Working capital
$258.14M
Debt to equity
0.1
Current ratio
4.78
Quick ratio
3.84
Net debt/EBITDA
2.56
Margins
Efficiency
Dividend
EBITDA margin
-19.1%
Gross margin
74%
Net margin
-25.5%
Operating margin
-24.3%
Return on assets
-14.1%
Return on equity
-17.9%
Return on invested capital
-20.2%
Return on capital employed
-15.8%
Return on sales
-22%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STAA stock price
How has the Staar Surgical stock price performed over time
Intraday
5.08%
1 week
-1.03%
1 month
19.08%
1 year
-54.9%
YTD
-20.87%
QTD
9.02%
Financial performance
How have Staar Surgical's revenue and profit performed over time
Revenue
$279.13M
Gross profit
$206.55M
Operating income
-$67.73M
Net income
-$71.08M
Gross margin
74%
Net margin
-25.5%
The gross profit has declined by 19% year-on-year and by 14% since the previous quarter
The revenue has contracted by 14% YoY and by 11% from the previous quarter
STAA's gross margin is down by 6% YoY and by 3% QoQ
Price vs fundamentals
How does STAA's price correlate with its fundamentals
Growth
What is Staar Surgical's growth rate over time
Valuation
What is Staar Surgical stock price valuation
P/E
N/A
P/B
2.71
P/S
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.92
STAA's price to book (P/B) is 76% lower than its 5-year quarterly average of 11.5 and 31% lower than its last 4 quarters average of 3.9
Staar Surgical's equity has decreased by 12% QoQ and by 11% YoY
The stock's price to sales (P/S) is 75% less than its 5-year quarterly average of 13.4 and 29% less than its last 4 quarters average of 4.8
The revenue has contracted by 14% YoY and by 11% from the previous quarter
Efficiency
How efficient is Staar Surgical business performance
Dividends
What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STAA.
Financial health
How did Staar Surgical financials performed over time
STAA's quick ratio is down by 22% YoY and by 13% QoQ
The current ratio has contracted by 18% YoY and by 9% from the previous quarter
Staar Surgical's debt is 90% less than its equity
Staar Surgical's equity has decreased by 12% QoQ and by 11% YoY
The company's debt to equity rose by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.